Colgate-Palmolive Company CL has seen notable improvements in their stock pricing, with a 40% rise and trading at a 28% discount. In addition, investors are contemplating
CL as a perfect defensive stock. Despite some days of loss, the stock outperforms the S&P 500 and its rivals. The company's earnings and future outlook are impressive, leading to a surge in stock price. There is curiosity among short sellers about this beauty stock, with the stock hitting fresh highs.
Colgate-Palmolive is now considered a solid consumer staples stock and a top dividend stock with consistent dividend growth. Despite Deutsche Bank's recent downgrade, the stock still maintains a high-ranking momentum and is now among Morgan Stanley’s preferred stocks. Various details, like robust Q1 2024 performance, strong dividends, and increased 2024 forecasts, all indicate solid future prospects for
Colgate-Palmolive. However, some critics argue that
CL could be overpriced in today's market. Despite a downgrade, it still surpasses key metrics compared to Wall Street estimates. Therefore, it remains to be seen how future market conditions and company performance will affect Colgate-Palmolive's stock.
Colgate-Palmolive Company CL News Analytics from Fri, 15 Dec 2023 08:00:00 GMT to Sun, 15 Sep 2024 14:03:32 GMT -
Rating 8
- Innovation 4
- Information 6
- Rumor -2
